SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-14-292364
Filing Date
2014-08-04
Accepted
2014-08-04 06:34:03
Documents
13

Document Format Files

Seq Description Document Type Size
1 425 d768558d425.htm 425 260331
2 GRAPHIC g768555g23k14.jpg GRAPHIC 215307
3 GRAPHIC g768555g30d16.jpg GRAPHIC 106219
4 GRAPHIC g768555g51f86.jpg GRAPHIC 141326
5 GRAPHIC g768555g63l90.jpg GRAPHIC 129014
6 GRAPHIC g768555g72w86.jpg GRAPHIC 77755
7 GRAPHIC g768555g82b20.jpg GRAPHIC 232128
8 GRAPHIC g768555g96p83.jpg GRAPHIC 58777
9 GRAPHIC g768555tx_logo.jpg GRAPHIC 3153
10 GRAPHIC g768555tx_pg008a.jpg GRAPHIC 21161
11 GRAPHIC g768555tx_pg008aa.jpg GRAPHIC 7427
12 GRAPHIC g768555tx_pg008b.jpg GRAPHIC 14579
13 GRAPHIC g768555tx_pg012.jpg GRAPHIC 7093
  Complete submission text file 0001193125-14-292364.txt   1660877
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-14956 | Film No.: 141011441
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425